DavidMatthewNathanMD

Endocrinology • Boston, MA

Diabetes, Lipid Metabolism

Professor of Medicine, Massachusetts General Hospital

Join to view full profile

Dr. Nathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nathan's full profile

Already have an account?

Office
50 Staniford St
3rd Floor S50 3
Boston, MA 02114
Phone+1 617-726-2875

Fax+1 617-726-6781

Education & Training

Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980
Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1978
Icahn School of Medicine at Mount SinaiClass of 1975

Certifications & Licensure

MA State Medical License 1978 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2010-2014
Boston Magazine Castle Connolly, 2010, 2012
Elected Member The American Society for Clinical Investigation, 1994
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
Active, not recruiting
Phase 3
Epidemiology of Diabetes Interventions and Complications (EDIC) Start of enrollment: 1994 Apr 01
Active, not recruiting
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk Start of enrollment: 2007 Sep 01
Unknown status
Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics Start of enrollment: 2007 Nov 01
Completed
Phase 1
Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon Start of enrollment: 2005 Jun 01
Completed
Phase 3
TODAY Genetics Study Start of enrollment: 2008 Aug 01
Completed
Gestational Diabetes Mellitus and Cardiovascular Disease: The Role of Vascular Dysfunction Start of enrollment: 2009 Aug 01
Unknown status
TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study Start of enrollment: 2011 Mar 01
Completed
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

207 citations
Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham heart study
Daniel E. Singer, David M. Nathan, Keaven M. Anderson, Peter W.F. Wilson, Jane C. Evans
Diabetes. 1992-02-01
488 citations
Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study
David M. Nathan, Elizabeth Barrett-Connor, Jill P. Crandall, S. L. Edelstein, Ronald B. Goldberg
The Lancet. Diabetes & Endocrinology. 2015-11-01
849 citations
Long-term complications of diabetes mellitus
David M. Nathan
The New England Journal of Medicine. 1993-06-10

Journal Articles

Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes
Vivian Fonseca, David M Nathan, Jonathan Newman, The Journal of Clinical Endocrinology and Metabolism

Lectures

2nd Annual Diabetes Symposium: New Advances and Innovations
Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 10/11/2013
2nd Annual Diabetes Symposium: New Advances and Innovations
Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 10/11/2013
1st Annual Diabetes Symposium: New Advances and Innovations
Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 9/28/2012
Pathogenesis: Obesity and Type 2 Diabetes
47th Annual Meeting, Lisbon, Portugal
Pathogenesis: Obesity and Type 2 Diabetes
European Association for the Study of Diabetes, 47th Annual Meeting, Lisbon, Portugal
Multiday Outpatient Glycemic Control in Adolescents with Type 1 Diabetes Using a Bihormonal Bionic Pancreas: The Barton Center Summer Camp Study
Boston, MA - 6/15/2014
Join now to see all

Press Mentions

Continuous Glucose Monitors (CGMs) for Type 2 Diabetes: When and for Whom Are They Useful?May 29th, 2024
Time for a Diabetes Tune-UpJanuary 13th, 2023
Glucose-Lowering Meds Compared for Use with Metformin in T2DMOctober 5th, 2022
Join now to see all

Grant Support

Diabetes Prevention Program Outcome Study - Phase 2National Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
Glycemic Reduction Approaches For Treating Diabetes: An Effectiveness StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
Action For Health In Diabetes (Look Ahead)National Institute Of Diabetes And Digestive And Kidney Diseases2006–2011
Comparison Of Lantus And NPH Insulin In The DAWN PhenomenonNational Center For Research Resources2008
Clinical Trial: TodayNational Center For Research Resources2008
Clinical Trial: Diabetes Prevention Program Outcomes Study (DPPOS)National Center For Research Resources2008
Treatment Options For Type 2 Diabetes In Adolescents And Youth (TODAY)National Center For Research Resources2005–2008
Look Ahead: Action For Health In DiabetesNational Center For Research Resources2004–2008
Post-Dpp Followup StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2008
TodayNational Center For Research Resources2005–2007
Assessing Energy Needs Of Overweight And Obese Individuals: A Comparison Of MENational Center For Research Resources2005–2007
Diabetes Prevention Program Outcomes Study (DPPOS)National Center For Research Resources2004–2007
Partners Roche Type 2 Diabetes ProjectNational Center For Research Resources2004–2005
SHOW ProjectNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2005
Diabetes Prevention Program (DPP)National Center For Research Resources2004
Clinical Center For Look Ahead: Health In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
Epidemiology Of Diabetes Intervention &Complications (EDIC)National Center For Research Resources1999–2002
Administration Of GLP 1 By Subcutaneous Delivery--Determination Of DoseNational Center For Research Resources1999–2002
Diabetes Prevention ProgramNational Center For Research Resources1997–2002
Diabetes Prevention Program (Ddp-2)National Institute Of Diabetes And Digestive And Kidney Diseases1996–2002
Diabetes Prevention PROGRAM: Screening STEP 2National Center For Research Resources2000
GLP-1 By Continous Subcutaneous Delivery--Determination Of DoseNational Center For Research Resources1999
Insulin Infusion In Type 1 Diabetes Using Implantable PUMPNational Center For Research Resources1998–1999
Epidemiology Of Diabetes Intervention And ComplicationsNational Center For Research Resources1996–1999
Investigation Of GLP I, 7-37 (INSULINOTROPIN) In Human SubjectsNational Center For Research Resources1997
GRF Determination For The Diabetes Control And Complications TrialNational Center For Research Resources1996
Diabetes Control And Complications TrialNational Center For Research Resources1996
Primary Prevention Trial (Dpt-2)National Institute Of Diabetes And Digestive And Kidney Diseases1994–1995
Diabetes Control And Complications TrialNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1994
Diabetes Control &Complications Trial (DCCT)National Institute Of Diabetes And Digestive And Kidney Diseases1986
Diabetes Control And Complications Trial (DCCT)Nat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985